It bypasses the skin barrier problem entirely
In the semaglutide group, the researchers saw significant changes between baseline and 32 weeks for high-sensitivity C-reactive protein (a 39.9% decrease), interleukin-6 (a 18.8% decrease) and soluble CD163, a marker of macrophage activation (a 12.3% decrease)
doi: 10.1089/dia.2019.0142 Summary Keywords adolescents, barriers, continuous glucose monitors, glycemic control, type 2 diabetes, youth Citation Manfredo J, Lin T, Gupta R, Abiola K, West M, Busin K, Tracey J, Brown EA, Magge SN and Wolf RM (2023) Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications
Whether your feet are worn down due to aging or to recent weight loss, we're here to help